Stay updated with breaking news from Finalis Securities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 3-ready latiglutenase, a targeted oral biotherapeutic for celiac disease, will expand First Wave BioPharma’s late-stage gastrointestinal disease clinical pipeline A concurrent institutional...
CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ('BWB' or the “Company”) today announced the acquisition of...
CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (NASDAQ:BWV) ("BWB" or the "Company") today announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics oncology
Labcorp Plans to Develop and Commercialize the Innovative Prostate Cancer Liquid Biopsy Test in the U.S. Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced
New Financing to Meet Significant Growth in Global Demand for MolecuLight's i:X and DX Point-of-Care Imaging Devices for the Wound Care Industry TORONTO, Aug. 11, 2022 /PRNewswire/ -- MolecuLight